FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2001024135> ?p ?o ?g. }

• W2001024135 endingPage "154" @default.
• W2001024135 startingPage "148" @default.
• W2001024135 abstract "The Aurora kinases play a key role in mitosis and have recently been identified as attractive targets for therapeutic intervention in cancer. The aim of this study was therefore to investigate the utility of 3′-[18F]fluoro-3′-deoxythymidine (FLT) and 2-deoxy-2-[18F]fluoro-D-glucose (FDG) for assessment of tumor response to the multi-targeted Aurora B kinase inhibitor, TAK-901. Balb/c nude mice bearing HCT116 colorectal xenografts were treated with up to 30 mg/kg TAK 901 or vehicle intravenously twice daily for two days on a weekly cycle. Tumor growth was monitored by calliper measurements and PET imaging was performed at baseline, day 4, 8, 11 and 15. Tumors were harvested at time points corresponding to days of PET imaging for analysis of ex vivo markers of cell proliferation and metabolism together with markers of Aurora B kinase inhibition including phospho-histone H3 (pHH3) and senescence associated β-galactosidase. Tumor growth was inhibited by 60% on day 12 of 30 mg/kg TAK-901 therapy. FLT uptake was significantly reduced by day 4 of treatment and this corresponded with reduction in bromodeoxyuridine and pHH3 staining by immunohistochemistry. All biomarkers rebounded towards baseline levels by the commencement of the next treatment cycle, consistent with release of Aurora B kinase suppression. TAK-901 therapy had no impact on glucose metabolism as assessed by FDG uptake and GLUT1 staining by immunohistochemistry. FLT-PET, but not FDG-PET, is a robust non-invasive imaging biomarker of early HCT116 tumor response to the on-target effects of the multi-targeted Aurora B kinase inhibitor, TAK-901. This is the first report to demonstrate the impact of the multi-targeted Aurora B kinase inhibitor, TAK-901 on tumor FLT uptake. The findings provide a strong rationale for the evaluation of FLT-PET as an early biomarker of tumor response in the early phase clinical development of this compound." @default.
• W2001024135 created "2016-06-24" @default.
• W2001024135 creator A5015560149 @default.
• W2001024135 creator A5020515172 @default.
• W2001024135 creator A5025954491 @default.
• W2001024135 creator A5040901155 @default.
• W2001024135 creator A5060586557 @default.
• W2001024135 creator A5063386653 @default.
• W2001024135 creator A5067671868 @default.
• W2001024135 creator A5089405869 @default.
• W2001024135 date "2014-02-01" @default.
• W2001024135 modified "2023-09-25" @default.
• W2001024135 title "Preclinical FLT-PET and FDG-PET imaging of tumor response to the multi-targeted Aurora B kinase inhibitor, TAK-901" @default.
• W2001024135 cites W1971947883 @default.
• W2001024135 cites W1978497190 @default.
• W2001024135 cites W1980577287 @default.
• W2001024135 cites W1982959429 @default.
• W2001024135 cites W1999178824 @default.
• W2001024135 cites W2007578216 @default.
• W2001024135 cites W2009292054 @default.
• W2001024135 cites W2014567183 @default.
• W2001024135 cites W2042118988 @default.
• W2001024135 cites W2042668154 @default.
• W2001024135 cites W2046193136 @default.
• W2001024135 cites W2048791428 @default.
• W2001024135 cites W2056913687 @default.
• W2001024135 cites W2097303935 @default.
• W2001024135 cites W2098801882 @default.
• W2001024135 cites W2101017561 @default.
• W2001024135 cites W2110555361 @default.
• W2001024135 cites W2112937643 @default.
• W2001024135 cites W2113720689 @default.
• W2001024135 cites W2113929218 @default.
• W2001024135 cites W2139070298 @default.
• W2001024135 cites W2143180849 @default.
• W2001024135 cites W2152450078 @default.
• W2001024135 cites W2153081604 @default.
• W2001024135 cites W2160475600 @default.
• W2001024135 cites W2168881161 @default.
• W2001024135 cites W2171919275 @default.
• W2001024135 doi "https://doi.org/10.1016/j.nucmedbio.2013.11.001" @default.
• W2001024135 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24332383" @default.
• W2001024135 hasPublicationYear "2014" @default.
• W2001024135 type Work @default.
• W2001024135 sameAs 2001024135 @default.
• W2001024135 citedByCount "11" @default.
• W2001024135 countsByYear W20010241352014 @default.
• W2001024135 countsByYear W20010241352015 @default.
• W2001024135 countsByYear W20010241352017 @default.
• W2001024135 countsByYear W20010241352018 @default.
• W2001024135 countsByYear W20010241352019 @default.
• W2001024135 countsByYear W20010241352020 @default.
• W2001024135 countsByYear W20010241352023 @default.
• W2001024135 crossrefType "journal-article" @default.
• W2001024135 hasAuthorship W2001024135A5015560149 @default.
• W2001024135 hasAuthorship W2001024135A5020515172 @default.
• W2001024135 hasAuthorship W2001024135A5025954491 @default.
• W2001024135 hasAuthorship W2001024135A5040901155 @default.
• W2001024135 hasAuthorship W2001024135A5060586557 @default.
• W2001024135 hasAuthorship W2001024135A5063386653 @default.
• W2001024135 hasAuthorship W2001024135A5067671868 @default.
• W2001024135 hasAuthorship W2001024135A5089405869 @default.
• W2001024135 hasConcept C141937037 @default.
• W2001024135 hasConcept C142724271 @default.
• W2001024135 hasConcept C1491633281 @default.
• W2001024135 hasConcept C150903083 @default.
• W2001024135 hasConcept C184235292 @default.
• W2001024135 hasConcept C204232928 @default.
• W2001024135 hasConcept C207001950 @default.
• W2001024135 hasConcept C26291073 @default.
• W2001024135 hasConcept C2778260397 @default.
• W2001024135 hasConcept C2781197716 @default.
• W2001024135 hasConcept C47432576 @default.
• W2001024135 hasConcept C502942594 @default.
• W2001024135 hasConcept C54355233 @default.
• W2001024135 hasConcept C55493867 @default.
• W2001024135 hasConcept C71924100 @default.
• W2001024135 hasConcept C85813293 @default.
• W2001024135 hasConcept C86803240 @default.
• W2001024135 hasConcept C95444343 @default.
• W2001024135 hasConceptScore W2001024135C141937037 @default.
• W2001024135 hasConceptScore W2001024135C142724271 @default.
• W2001024135 hasConceptScore W2001024135C1491633281 @default.
• W2001024135 hasConceptScore W2001024135C150903083 @default.
• W2001024135 hasConceptScore W2001024135C184235292 @default.
• W2001024135 hasConceptScore W2001024135C204232928 @default.
• W2001024135 hasConceptScore W2001024135C207001950 @default.
• W2001024135 hasConceptScore W2001024135C26291073 @default.
• W2001024135 hasConceptScore W2001024135C2778260397 @default.
• W2001024135 hasConceptScore W2001024135C2781197716 @default.
• W2001024135 hasConceptScore W2001024135C47432576 @default.
• W2001024135 hasConceptScore W2001024135C502942594 @default.
• W2001024135 hasConceptScore W2001024135C54355233 @default.
• W2001024135 hasConceptScore W2001024135C55493867 @default.
• W2001024135 hasConceptScore W2001024135C71924100 @default.
• W2001024135 hasConceptScore W2001024135C85813293 @default.
• W2001024135 hasConceptScore W2001024135C86803240 @default.
• W2001024135 hasConceptScore W2001024135C95444343 @default.

• next